Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Receivables - Other (2023)

Historic Receivables - Other for Immunome (IMNM) over the last 1 years, with Q4 2023 value amounting to $289000.0.

  • Immunome's Receivables - Other changed N/A to $289000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $289000.0, marking a year-over-year change of. This contributed to the annual value of $289000.0 for FY2023, which is N/A changed from last year.
  • Immunome's Receivables - Other amounted to $289000.0 in Q4 2023.
  • Immunome's 5-year Receivables - Other high stood at $821000.0 for Q1 2023, and its period low was $208000.0 during Q2 2023.